These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 22406443

  • 1. A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer's disease.
    Alegret M, Cuberas-Borrós G, Vinyes-Junqué G, Espinosa A, Valero S, Hernández I, Roca I, Ruíz A, Rosende-Roca M, Mauleón A, Becker JT, Castell-Conesa J, Tárraga L, Boada M.
    J Alzheimers Dis; 2012; 30(1):109-20. PubMed ID: 22406443
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment.
    Habert MO, Horn JF, Sarazin M, Lotterie JA, Puel M, Onen F, Zanca M, Portet F, Touchon J, Verny M, Mahieux F, Giron A, Fertil B, Dubois B.
    Neurobiol Aging; 2011 Jan; 32(1):15-23. PubMed ID: 19250707
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cerebral Blood Flow Predicts Conversion of Mild Cognitive Impairment into Alzheimer's Disease and Cognitive Decline: An Arterial Spin Labeling Follow-up Study.
    Duan W, Zhou GD, Balachandrasekaran A, Bhumkar AB, Boraste PB, Becker JT, Kuller LH, Lopez OL, Gach HM, Dai W.
    J Alzheimers Dis; 2021 Jan; 82(1):293-305. PubMed ID: 34024834
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Amyloid deposition and CBF patterns predict conversion of mild cognitive impairment to dementia.
    Kikukawa T, Abe T, Ataka S, Saito H, Hasegawa I, Mino T, Takeuchi J, Kawabe J, Wada Y, Watanabe Y, Itoh Y.
    Neurol Sci; 2018 Sep; 39(9):1597-1602. PubMed ID: 29936556
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Single-photon emission computed tomography (SPECT) perfusion and neuropsychological performance in mild cognitive impairment.
    Van Patten R, Greif T, Britton K, Tremont G.
    J Clin Exp Neuropsychol; 2019 Jul; 41(5):530-543. PubMed ID: 30880594
    [Abstract] [Full Text] [Related]

  • 15. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC, Gaser C, Franke K, Alzheimer’s Disease Neuroimaging Initiative.
    PLoS One; 2016 Jul; 11(7):e0157514. PubMed ID: 27410431
    [Abstract] [Full Text] [Related]

  • 16. Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain 1H-MRS and volumetric changes: A two- year retrospective follow-up study.
    Mitolo M, Stanzani-Maserati M, Capellari S, Testa C, Rucci P, Poda R, Oppi F, Gallassi R, Sambati L, Rizzo G, Parchi P, Evangelisti S, Talozzi L, Tonon C, Lodi R, Liguori R.
    Neuroimage Clin; 2019 Jul; 23():101843. PubMed ID: 31071594
    [Abstract] [Full Text] [Related]

  • 17. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J, Marecek R, Klobusiakova P, Balazova Z, Anderkova L, Nemcova-Elfmarkova N, Rektorova I.
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic approach with Z-score mapping to reduce artifacts caused by cerebral atrophy in regional CBF assessment of mild cognitive impairment (MCI) and Alzheimer's disease by [99mTc]-ECD and SPECT.
    Odano I, Maeyatsu F, Hosoya T, Asari M, Oba K, Taki Y.
    Jpn J Radiol; 2024 May; 42(5):508-518. PubMed ID: 38351252
    [Abstract] [Full Text] [Related]

  • 19. Risk estimation before progression to mild cognitive impairment and Alzheimer's disease: an AD resemblance atrophy index.
    Zhao L, Luo Y, Lew D, Liu W, Au L, Mok V, Shi L, Alzheimer Disease Neuroimaging InitiativeData used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf..
    Aging (Albany NY); 2019 Aug 29; 11(16):6217-6236. PubMed ID: 31467257
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.